At EMERGE 4LIFE PARTNERS, we are thrilled to announce a significant milestone in our journey: our strategic investment in Core Process, a leading company in advanced process solutions for the pharmaceutical industry. Specializing in the design, manufacturing, and delivery of reactors and bioreactors, Core Process is transforming the optimization of production processes in the sector.

This partnership not only provides the capital needed to accelerate Core Process’s growth but also underscores our active commitment to its development. As part of this collaboration, EMERGE 4LIFE PARTNERS has joined the company’s Board of Directors, bringing expertise, strategic vision, and strong support to help drive its global expansion.

Oriol Casòliva, President and Founder of EMERGE 4LIFE PARTNERS, emphasized:
“Core Process has shown unparalleled passion for innovation and technical excellence, redefining industry standards in the pharmaceutical sector. We are proud to accompany them in this exciting growth phase.”

Under the leadership of Toni Gris, Core Process is perfectly positioned to solidify its role as a key player in the industry. Its ability to deliver cutting-edge solutions is setting new benchmarks for efficiency and quality in pharmaceutical processes.

For EMERGE 4LIFE PARTNERS, this investment represents another step forward in our mission to partner with emerging companies that share our vision: positively impacting people’s lives through innovation in life sciences.

Want to learn more about how we are shaping a brighter future in the pharmaceutical and biotech sectors?

Emerge 4 Life Partners

Core Process